Oral guanfacine (2 mg; as in refs 14 16) was encapsulated by Nova Pharmaceuticals, which also provided matching placebo. Patients were tested on five consecutive days. On days 1, 3 and 5, they were ...

Researchers in the UK have shown that guanfacine could help to combat leftward spatial exploration deficit in patients with visual neglect due to right-hemisphere stroke. The noradrenergic ...